Kingsbarn Realty Capital Buys Six-Property Portfolio for DST Offering
Private equity firm Kingsbarn Realty Capital has purchased a 50,000-square-foot portfolio of six healthcare properties located in South Carolina, Kentucky, Wisconsin, Tennessee and Pennsylvania for an undisclosed amount.
Private equity firm Kingsbarn Realty Capital has purchased a 50,000-square-foot portfolio of five dialysis centers and one Walgreens located in South Carolina, Kentucky, Wisconsin, Tennessee and Pennsylvania for an undisclosed amount.
The six properties will be pooled together in a Delaware statutory trust and offered to individual 1031 exchange buyers by the company’s sponsor, KB Exchange Trust.
Kingsbarn Realty Capital focuses on acquiring credit-tenant healthcare properties located throughout the United States. Property portfolios are structured as Delaware statutory trusts and offer ownership opportunities for accredited investors seeking 1031 exchange replacement properties.
Section 1031 of the Internal Revenue Code allows investors to defer paying capital gains taxes on investment property sales by reinvesting the proceeds into a similar investment property within a specified time frame.
Four of the properties are leased to Fresenius Medical Care Holdings Inc., a wholly owned subsidiary of Fresenius Medical Care (NYSE: FMS), a provider of dialysis treatment products.
The remaining two properties are leased to DaVita Kidney Care (NYSE: DVA), a kidney care provider in the United States with more than 2,700 locations, and U.S. pharmacy chain, Walgreens (NASDAQ: WBA).
“Due to increasing demand for healthcare properties, and growing trends in passive 1031 real estate ownership, we have created those investment opportunities for our clients,” says Jeff Pori, CEO of Kingsbarn.
Kingsbarn’s real estate investment programs are offered through Triloma Securities.
Kingsbarn Realty Capital is a real estate private equity firm that structures its real estate investment opportunities for both fractional 1031 investors as well as large scale investors seeking single allocations.